) -- Shares of

BioSpecifics Technologies Corporation



) have taken a tremendous swing upward. The stock is trading at $20.82 as of 12:26 p.m. ET, 28.9% above Wednesday's closing price of $16.15. Volume is at 3,343, 0.2 times the daily average of 16,100.

BioSpecifics has a market cap of $101.8 million and is part of the

health care

sector and


industry. Shares are down 36.9% year to date as of the close of trading on Wednesday.

Biospecifics Technologies Corp., a biopharmaceutical company, involves in the development of an injectable collagenase for various indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company has a P/E ratio of 19.5, below the average drugs industry P/E ratio of 19.8 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates BioSpecifics as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full

BioSpecifics Ratings Report


See our

top % gaining stocks list

for other stocks that are soaring today, or get investment ideas from our

investment research center


Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options